Log in

Relevant bibliographies by topics / Uso medicinal del cannabidiol / Journal articles

To see the other types of publications on this topic, follow the link: Uso medicinal del cannabidiol.

Journal articles on the topic 'Uso medicinal del cannabidiol'

Author: Grafiati

Published: 5 June 2025

Last updated: 2 August 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Uso medicinal del cannabidiol.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Sheila, Pincinato, Pereira Mamede da Silva Rayssa, Ferreira dos Santos Quezia, et al. "PRESCRIÇÃO INDISCRIMINADA DA CANNABIS SATIVA POR PROFISSIONAIS DA MEDICINA VETERINÁRIA NA REGIÃO SUDESTE DO BRASIL: ESTUDO DE CASO." Revistaft 27, no. 118 (2023): 71. https://doi.org/10.5281/zenodo.7542471.

Full text

Abstract:

A Cannabis sativa é uma planta asiática e tem sido utilizada pelo homem há séculos para diversos fins, incluindo o uso medicinal. Constituída por diversos compostos, ela apresenta níveis elevados de THC (tetrahidrocanabinol) e de CBD (canabidiol) tornando-a uma planta de propriedades terapêuticas. Na Medicina Veterinária vem sendo utilizada no tratamento de diversas enfermidades, porém, ainda sem legislação e regulamentação específicas. Sendo assim, o presente trabalho tem por objetivo principal re

APA, Harvard, Vancouver, ISO, and other styles

2

Pereira, Antônio Matheus Oliveira, Ana Carolina Santiago Masini, Clara de Almeida e. Araujo Leite, et al. "Integrando o uso do cannabidiol na formação médica: enfoque na ética e cuidado ao paciente." Brazilian Journal of Health Review 7, no. 1 (2024): 4809–31. http://dx.doi.org/10.34119/bjhrv7n1-389.

Full text

Abstract:

Introdução: A cannabis possui mais de uma centena de componentes químicos, incluindo delta-9-tetrahidrocanabinol (THC) e canabidiol (CBD). Essas substâncias revelaram um amplo espectro de efeitos biológicos, abrindo portas para o tratamento de condições médicas. Embora muitos países tenham legalizado e regulamentado progressivamente o uso medicinal da cannabis, o Brasil enfrenta um cenário jurídico complexo. Serão abordadas as propriedades terapêuticas dos canabinóides, os seus mecanismos de ação subjacentes e as implicações legais envolvidas. Do ponto de vista jurídico, apresentaremos o alcan

APA, Harvard, Vancouver, ISO, and other styles

3

Hayashida, Bianca Ayumi Parreira, Camila Alexandre Alves Moura, and Ramon Fraga de Souza Lima. "TRATAMENTO PARA EPILEPSIA COM USO DE CANABIDIOL." Revista ft 29, no. 142 (2025): 40–41. https://doi.org/10.69849/revistaft/ar10202501180140.

Full text

Abstract:

Dravet syndrome (DS), Lennox-Gastaut syndrome (LGS) and tuberous sclerosis complex (TSC) are extremely serious diseases present in the central nervous system that cause epileptic seizures that are refractory to conventional medications. Therefore, the objective of this study was to describe the effectiveness and the need for expanding studies and government measures on the use of medicinal cannabis as an alternative treatment for refractory epileptic seizures. The PubMed and BVS databases were used with the descriptors “Treatment”, “Epilepsy”, “Cannabidiol”, and the inclusion criteria used wer

APA, Harvard, Vancouver, ISO, and other styles

4

Oliveira, Milena Edite Casé de, Kedma Anne Lima Gomes, Waleska Fernanda Souto Nóbrega, et al. "Cannabis e Câncer de mama: Evidências com células in vitro." Research, Society and Development 10, no. 10 (2021): e09101018387. http://dx.doi.org/10.33448/rsd-v10i10.18387.

Full text

Abstract:

O câncer de mama é considerado o câncer mais incidente em mulheres no mundo. Evidências tem mostrado que os canabinoides podem modular vias de sinalização responsáveis pelo crescimento e para a propagação do câncer. Dessa forma, a presente revisão da literatura buscou sumarizar as evidências existentes até então, acerca do uso da cannabis para o tratamento do câncer de mama. A coleta de dados foi realizada no período de maio a junho de 2021, na base de dados eletrônica PubMed. Foram incluídos artigos desde sua origem até 01 de junho de 2021, com a combinação dos seguintes descritores: ((Cannab

APA, Harvard, Vancouver, ISO, and other styles

5

Speranza Mourine, Noelia, Agustina De Santis, Irene Wood, et al. "¿Quiénes prescriben cannabis medicinal en Uruguay?:." Anales de la Facultad de Medicina 12, no. 1 (2025): e205. https://doi.org/10.25184/anfamed2025v12n1a8.

Full text

Abstract:

Introducción: El interés terapéutico por los cannabinoides de uso medicinal se ha incrementado recientemente. Objetivo: Realizar un estudio preliminar para conocer la prevalencia y el perfil de los prescriptores de cannabis medicinal en Uruguay durante mayo-julio 2022 y la respuesta clínica observada. Materiales y métodos: Se realizó un estudio observacional, descriptivo y transversal, a través de una encuesta. Resultados: Se analizaron 88 respuestas, siendo 21 médicos prescriptores (prescriptores) y 67 no prescriptores (no prescriptores) de cannabinoides de uso medicinal. El principal motivo

APA, Harvard, Vancouver, ISO, and other styles

6

Gomes, Pamela, Ricardo Teixeira Vieira, Matheus Cardoso Marques Ferreira, and Leonardo Miranda Feitosa. "Uso medicinal do cannabidiol no tratamento da epilepsia: revisão integrativa de literatura." Brazilian Journal of Health Review 7, no. 2 (2024): e68326. http://dx.doi.org/10.34119/bjhrv7n2-194.

Full text

Abstract:

A epilepsia é uma doença neurológica crônica que afeta o cérebro e pode causar convulsões ou crises epilépticas. É caracterizada por uma atividade elétrica anormal do cérebro, causado por predisposição genética, que pode levar a sintomas como convulsões, perda de consciência, movimentos involuntários, alterações de humor, perda de memória e outros sintomas neurológicos. A epilepsia pode ter diversas causas, como traumas cerebrais, infecções, anomalias cerebrais congênitas, entre outras. O tratamento da epilepsia pode incluir medicamentos antiepiléticos, cirurgia, estimulação cerebral profunda

APA, Harvard, Vancouver, ISO, and other styles

7

Riley, Jessica A., M. Laurie Branstetter, M. Eve Main, and M. Susan Jones. "A Pilot Study: Using the Health Belief Model to Understand Cannabidiol Use in One Amish Community." Journal of Plain Anabaptist Communities 2, no. 2 (2022): 69–84. http://dx.doi.org/10.18061/jpac.v2i2.8668.

Full text

Abstract:

Amish use of complementary and alternative medicine is common, but little is known about their opinion of cannabidiol. Hemp legalization has popularized cannabidiol, making it available to Amish whose traditions limit access to scientific information. The purpose of this pilot study is to gain an understanding of cannabidiol use in one Old Order Amish community. A researcher-developed questionnaire was mailed to 60 members of one Amish district. The Medicinal Cannabidiol Survey for an Amish Population was adapted from the Medicinal Cannabis Survey for General Practitioners to the specification

APA, Harvard, Vancouver, ISO, and other styles

8

Santos, Nathalia Caroline Medeiros dos, Fabiana Sousa Pugliese, and Leonardo Guimarães de Andrade. "THE USE OF CANNABIDIOL IN PATIENTS WITH EPILEPSY." Revista Ibero-Americana de Humanidades, Ciências e Educação 10, no. 5 (2024): 407–21. http://dx.doi.org/10.51891/rease.v10i5.13795.

Full text

Abstract:

A epilepsia é uma condição neurológica crônica caracterizada por convulsões recorrentes. Essas convulsões são causadas por atividade elétrica anormal no cérebro, que pode levar a episódios de perda de consciência, movimentos involuntários, sensações estranhas e outros sintomas, dependendo da área do cérebro afetada. Embora a epilepsia seja mais comum em adultos mais velhos, ela também pode ocorrer em crianças em uma proporção significativa. Nesse contexto, o canabidiol (CBD), composto químico encontrado na planta de cannabis, estudado por seus potenciais benefícios terapêuticos, que incluem al

APA, Harvard, Vancouver, ISO, and other styles

9

Érica, Motta Moreira de Souza, Alves Ribeiro Wanderson, Costa Soares Denilson, et al. "O TRABALHO DA ENFERMAGEM NA SAÚDE COM USUÁRIOS DE DROGAS E ÁLCOOL. CANNABIS MEDICINAL: NOSSO PAÍS ESTÁ PREPARADO?" RevistaFT 27, no. 124 (2023): 81. https://doi.org/10.5281/zenodo.8161181.

Full text

Abstract:

O presente artigo trata-se de uma revisão bibliográfica afim de analisar a atuação do enfermeiro em virtude do acentuado aumento dos casos diagnosticados de dependência química, além da observância sobre a liberação e as possibilidades do uso da planta Cannabis de forma terapêutica no Brasil. Desenvolve de forma qualitativa, abordando conceito históricos, desde a proibição do uso da planta, como a elaboração de decretos que foram tramitados sobre liberação do uso da terap&

APA, Harvard, Vancouver, ISO, and other styles

10

Weust, Jan. "Hospital Policy Regarding Medicinal Marijuana and Cannabidiol Use." MEDSURG Nursing 33, no. 5 (2024): 253. http://dx.doi.org/10.62116/msj.2024.33.5.253.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Cabello Ayzama, Alex, and José Renato Venâncio Resende. "Consideraciones Generales sobre el Uso Medicinal del Cannabis Sativa; la Garantía del Derecho a la Salud." Revista Compás Empresarial 10, no. 29 (2019): 50–61. http://dx.doi.org/10.52428/20758960.v10i29.300.

Full text

Abstract:

La marihuana es una planta del género Cannabis sativa de la que se extraen unos 400 compuestos, de los cuales se destacan el tetrahidrocannabinol (THC) y el cannabidiol (CBD); conocidos desde la década de 1960 y utilizados ampliamente en el tratamiento de enfermedades refractarias. Sin embargo, en Bolivia y Brasil esas sustancias todavía se consideran estupefacientes y su producción y uso, aunque medicinal, son sancionados penalmente. Este artículo se propone investigar la posibilidad de ampliación por el Estado del acceso a esos medicamentos, como una garantía del derecho fundamental a la sal

APA, Harvard, Vancouver, ISO, and other styles

12

Castilhos Medeiros, Franciele, and Priscilla Bazzo Soares. "Uso medicinal de Cannabis sativa (Cannabaceae) como alternativa en tratamiento de la epilepsia." Revista Boaciencia. Saúde e Meio Ambiente 1, no. 2 (2021): 110–26. http://dx.doi.org/10.59801/sma.v1i2.19.

Full text

Abstract:

Existen informes sobre el uso de la planta Cannabis sativa con fines medicinales en el tratamiento de diversas enfermedades. Su uso es antiguo y actualmente la planta ha sido estudiada para el tratamiento de enfermedades como el glaucoma, ataques epilépticos y el alivio de dolores y espasmos musculares. EL principal compuesto químico estudiado en la planta es el cannabidiol, al no ser psicoactivo, que actúa sobre diversos sistemas receptores sin presentar efectos adversos tóxicos. Esta revisión tiene cómo tienen como objetivo analizar los beneficios de Cannabis sativa y su uso terapéutico para

APA, Harvard, Vancouver, ISO, and other styles

13

Díaz Rodríguez, Laura Sofía, Alejandra Elizabeth López Mirón, and Alberto Armando Romero Olmedo. "Uso de cannabidiol para el control de síntomas refractarios en síndromes convulsivos y enfermedades neurodegenerativas." Alerta, Revista científica del Instituto Nacional de Salud 6, no. 1 (2023): 78–85. http://dx.doi.org/10.5377/alerta.v6i1.15563.

Full text

Abstract:

Como parte de las terapias alternativas para el control de síntomas refractarios en enfermedades avanzadas destaca el uso de cannabidiol. Este se ha estudiado en patologías como enfermedad de Alzheimer, Parkinson y trastornos convulsivos. Los síndromes convulsivos están presentes en todos los grupos etarios. Dentro de este, la epilepsia es refractaria hasta en un 40 % de los pacientes, quienes han demostrado disminución en la frecuencia de convulsiones con el uso concomitante de cannabidiol y antiepilépticos convencionales, con efectos secundarios leves, como diarrea y somnolencia. Con el obje

APA, Harvard, Vancouver, ISO, and other styles

14

Silva Larrea, Amalia Gabriela, and Daniela Guadalupe Montenegro Arévalo. "THC y CBD una alternativa para el tratamiento del estrés en adultos: beneficios y controversias. Una revisión actualizada de la literatura." Anatomía Digital 7, no. 1.2 (2024): 143–56. http://dx.doi.org/10.33262/anatomiadigital.v7i1.2.3007.

Full text

Abstract:

Introducción. El estrés es un trastorno producido por situaciones físicas o emocionales que afectan la homeostasis del cuerpo ocasionando cambios significativos en la salud. En el siglo XXI se han desarrollado terapias basadas en plantas medicinales, incluyendo aquellas que pueden tratar enfermedades del Sistema Nervioso Central. El uso de fitocannabinoides como THC y CBD han demostrado ser efectivos para reducir el estrés, pero han generado controversia debido a su uso recreativo y regulaciones. Objetivo. El propósito de este artículo es revisar la evidencia científica actual sobre los efecto

APA, Harvard, Vancouver, ISO, and other styles

15

Jesus, João Vitor Silva Mendes De. "CANNABIS: USO TERAPÊUTICO E DESAFIOS PARA SUA APLICABILIDADE MEDICINAL NO BRASIL." Revista ft 28, no. 139 (2024): 48–49. http://dx.doi.org/10.69849/revistaft/ni10202410282148.

Full text

Abstract:

Introduction: The legalization of medicinal marijuana use has been a controversial and constantly debated topic in recent years worldwide. Marijuana, also known as cannabis, is a plant that contains various chemical components, including THC (tetrahydrocannabinol) and CBD (cannabidiol), which are the main compounds responsible for its medicinal effects. Although many countries have already established regulations for the therapeutic use of cannabis, there are still many barriers to overcome. Objective: To explore the methodology of therapeutic use and the challenges for the application of cann

APA, Harvard, Vancouver, ISO, and other styles

16

Sartório, Carmem Luíza, Deize Pereira Alexandrino Dias Santos, Lívia Carla de Melo Rodrigues, and Paulo José Lima Juíz. "Prospecção Tecnológica sobre o Uso Medicinal de Cannabis sativa para Tratamento da Covid-19." Cadernos de Prospecção 16, no. 2 (2023): 421–36. http://dx.doi.org/10.9771/cp.v16i2.51372.

Full text

Abstract:

A Covid-19 caracteriza-se por disfunções orgânicas que podem repercutir na qualidade de vida do paciente e gerar sobrecarga no atendimento clínico do sistema público de saúde. A Cannabis medicinal tem despertado o interesse na comunidade científica, visto que pesquisas comprovam a segurança, a eficácia, o restabelecimento da homeostase e a consequente desmedicalização. Portanto, o objetivo deste estudo foi verificar o desenvolvimento científico e tecnológico sobre o uso medicinal de produtos à base de Cannabis e seus princípios ativos na Covid-19. A sintaxe utilizada para acessar os dados foi

APA, Harvard, Vancouver, ISO, and other styles

17

Pesántez Ríos, Gabriela, Luciana Armijos Acurio, Ruth Jimbo Sotomayor, Samuel Ignacio Pascual Pascual, and Galo Pesántez Cuesta. "Cannabidiol: uso en epilepsias refractarias." Revista de Neurología 65, no. 04 (2017): 157. http://dx.doi.org/10.33588/rn.6504.2016573.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Colacite, Jean, Nicole Melo Calixto, Lais Picinin Bittencourt Rech, et al. "Uso de cannabidiol en el tratamiento del autismo, revisión de la literatura y perspectivas futuras." Research, Society and Development 13, no. 3 (2024): e5113341741. http://dx.doi.org/10.33448/rsd-v13i3.41741.

Full text

Abstract:

Los Trastornos del Espectro Autista (TEA) son considerados una enfermedad multifactorial, estando asociados a causas genéticas y no genéticas con predominio del desarrollo en la primera infancia y que compromete las esferas cognitiva, social y afectiva, además del propio crecimiento físico. No existen medicamentos específicos para el autismo y se utilizan varios medicamentos para aliviar los síntomas asociados con el TEA, además se tiene muy discusión sobre el uso de lo canabidiol. Este trabajo es una revisión sistemática de la literatura con el objetivo de comprender más sobre el uso del cann

APA, Harvard, Vancouver, ISO, and other styles

19

Martins Paloschi, Claudinei, and Cristian Basilio Díaz Cuevas. "Revisión Bibliográfica sobre el Uso de Canabidiol en Pacientes con Enfermedades Neurológicas en Mejora de la Calidad de Vida." Ciencia Latina Revista Científica Multidisciplinar 7, no. 6 (2023): 219–35. http://dx.doi.org/10.37811/cl_rcm.v7i6.8627.

Full text

Abstract:

La presente investigación trata de determinar el uso de Cannabidiol en el tratamiento de enfermedades neurológicas con el fin de mejorar la calidad de vida de las personas afectadas por ellas. Se realizó a una revisión bibliográfica a través de Google Académico incluyendo textos completos de artículos de revistas científicas, tesis de conclusión de cursos y otros trabajos académicos. Para la búsqueda de artículos se utilizaron los descriptores enfermedades neurológicas, tratamiento, Cannabidiol, siendo publicados en cualquier idioma. Se revisó 12 artículos científicos que obedecieron los crite

APA, Harvard, Vancouver, ISO, and other styles

20

Tsvetkova, Dobrina, Lily Peykova, Lily Andonova-Dimitrova, and Ivanka Pencheva. "Regulation and control of the use of Cannabis and Cannabidiol in „novel foods”." Pharmacia 70, no. 4 (2023): 1385–95. http://dx.doi.org/10.3897/pharmacia.70.e114938.

Full text

Abstract:

Cannabis sativa L. is a medicinal plant from family Cannabaceae with many pharmacological activities. The recent appearance of a number of cannabis products in the pharmaceutical market has led to increased requirements for regulation and quality control. The control of Cannabis sativa L. is subject to the Psychotropic Substances Convention, which includes the addictive psychoactive delta-9-tetrahydrocannabinol (THC), and to the Narcotic Drugs Convention, which includes the illicit products: herbal and liquid cannabis, resin, extracts and tinctures of flowering or fruiting tops containing THC.

APA, Harvard, Vancouver, ISO, and other styles

21

Jesus, Lozany Vieira de, Maiara Mendes Costa, Marcos Henrique Gonzales, and Oswaldo José Marcelino Neto. "A avaliação dos resultados no uso do canabidiol em criança com crises epiléticas." Research, Society and Development 12, no. 3 (2023): e7712340524. http://dx.doi.org/10.33448/rsd-v12i3.40524.

Full text

Abstract:

Objetivo: Investigar se o uso do Canabidiol em crianças com diagnóstico de Paralisia Cerebral, melhoram a função motora e diminuem as crises de epilepsia associada a esta patologia. Metodologia: Esta revisão integrativa da literatura foi realizada pela coleta de dados através de buscas dos estudos nas bases de dados: National Library of Medicine National Institutes of Health (PubMed) e Biblioteca Virtual de Saúde (BVS). Os critérios de inclusão irão considerar artigos originais, publicados em bases de dados online no período entre 2017 e 2022, em português, inglês e espanhol. Os descritores qu

APA, Harvard, Vancouver, ISO, and other styles

22

Tsvetkova, Dobrina, Lily Peykova, Lily Andonova-Dimitrova, and Ivanka Pencheva. "Regulation and control of the use of Cannabis and Cannabidiol in "novel foods"." Pharmacia 70, no. (4) (2023): 1385–95. https://doi.org/10.3897/pharmacia.70.e114938.

Full text

Abstract:

<i>Cannabis sativa</i> L. is a medicinal plant from family Cannabaceae with many pharmacological activities. The recent appearance of a number of cannabis products in the pharmaceutical market has led to increased requirements for regulation and quality control. The control of <i>Cannabis sativa</i> L. is subject to the Psychotropic Substances Convention, which includes the addictive psychoactive delta-9-tetrahydrocannabinol (THC), and to the Narcotic Drugs Convention, which includes the illicit products: herbal and liquid cannabis, resin, extracts and tinctures of flowering or fruiting tops c

APA, Harvard, Vancouver, ISO, and other styles

23

Velasco Barbosa Garcia, Isabella, Brenda Lauanny Ribeiro da Silva, Caroline Rodrigues Montozo Lopes, et al. "USO DA CANNABIS EM CÃES COM DOENÇAS CRÔNICAS: QUAIS AS EVIDÊNCIAS?" RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218 3, no. 9 (2022): e391742. http://dx.doi.org/10.47820/recima21.v3i9.1742.

Full text

Abstract:

Objetivo: O presente estudo tem como objetivo principal explorar o uso de Canabinóides nos casos de doenças crônicas na espécie canina, analisando sua relevância, farmacodinâmica, capacidade terapêutica e efeitos positivos e negativos no tratamento. Métodos: Foi realizada uma revisão narrativa que investigou a produção do conhecimento sobre o uso de Cannabis em cães com doenças crônicas e suas evidências. Foram pesquisadas as seguintes bases de dados: LILACS, MEDLINE, PUBMED e SciELO, no período de 2018 a 2022. Os termos de busca utilizados foram: Cannabis, dor crônica, cães, tratamento e qual

APA, Harvard, Vancouver, ISO, and other styles

24

Silva, Matheus Araujo, Bárbara de Souza Ferreira, Lucas Clayton Nunes da Silva, Larisse Gabriela Ferreira da Silva, Niedja Carla Lima Almeida, and Elton Sales Gomes Ribeiro. "IMPORTÂNCIA MEDICINAL DA CANNABIS SATIVA PARA O TRATAMENTO DA EPILEPSIA: UMA REVISÃO DA LITERATURA." REVISTA FOCO 17, no. 9 (2024): e6077. http://dx.doi.org/10.54751/revistafoco.v17n9-024.

Full text

Abstract:

A epilepsia é uma doença cerebral crônica caracterizada pela recorrência de crises epilépticas não provocadas. Esta condição tem consequências, cognitivas, psicológicas e sociais e prejudica diretamente a qualidade de vida do indivíduo afetado. Estima-se que cerca de 30% dos pacientes sejam refratários, ou seja, continuam a ter crises, sem remissão, apesar de tratamento adequado com medicamentos anticonvulsivantes. A partir dessa situação, tem se buscado outras drogas para se conseguir amenizar os efeitos das crises. Disso, decidiu-se fazer o uso da Cannabis sativa como medicamento, mais espec

APA, Harvard, Vancouver, ISO, and other styles

25

Kaushik, Heena, Brijender Singh Tomar, and Satbir Kumar Chawla. "Review Article on Role of Bhanga(Cannabis) in Pain Management." International Research Journal of Ayurveda & Yoga 06, no. 06 (2023): 157–62. http://dx.doi.org/10.47223/irjay.2023.6626.

Full text

Abstract:

Bhanga(Cannabis) has been an integral part of the Indian system of medicine and Indian culture from centuries. During Holi(the festival of colors) there is an increased availability and consumption of Bhangaand in Maha-ShivratriBhangais consumed because of its deliriant effect. However, since the consumption of Bhangamajorly falls under the category of recreational marijuana use, its exceptional medicinal values are not explored in-depth.However, during the last decade, interest in cannabis in medicinal use has been increasing. In many countries like the USA, UK etc. implementing their regulat

APA, Harvard, Vancouver, ISO, and other styles

26

Victoria Pereira Simão, Gabriel Mota Zamariolli Tavares, Gabriel Silva Santos, et al. "The clinical use of cannabinoids for pain." World Journal of Advanced Research and Reviews 21, no. 3 (2024): 1295–302. http://dx.doi.org/10.30574/wjarr.2024.21.3.0754.

Full text

Abstract:

Cannabis has been used for medicinal purposes more than millennia., further research concerning the potential applications of medicinal cannabis has gained considerable momentum in the medical community. Among the several cannabinoids produced by cannabis leaves, the most notable compounds include Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD), which act on the endocannabinoid system and play significant physiological roles, such as pain regulation. This manuscript reviews the current knowledge and provides medical evidence about the analgesic potential of medicinal cannabis for chronic p

APA, Harvard, Vancouver, ISO, and other styles

27

Victoria, Pereira Simão, Mota Zamariolli Tavares Gabriel, Silva Santos Gabriel, et al. "The clinical use of cannabinoids for pain." World Journal of Advanced Research and Reviews 21, no. 3 (2024): 1295–302. https://doi.org/10.5281/zenodo.14071482.

Full text

Abstract:

Cannabis has been used for medicinal purposes more than millennia., further research concerning the potential applications of medicinal cannabis has gained considerable momentum in the medical community. Among the several cannabinoids produced by cannabis leaves, the most notable compounds include Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD), which act on the endocannabinoid system and play significant physiological roles, such as pain regulation. This manuscript reviews the current knowledge and provides medical evidence about the analgesic potential of medicinal cannabis for chr

APA, Harvard, Vancouver, ISO, and other styles

28

Garcia Leite Pavanetti, Gustavo, Cláudia Viccario Amantini, Danielle Delgado Diaz Medina, et al. "The use of medicinal cannabis as an alternative treatment for depressive disorders: integrative review." Concilium 24, no. 9 (2024): 298–311. http://dx.doi.org/10.53660/clm-3382-24i10.

Full text

Abstract:

Objective: to analyze, through an integrative review, the use and applicability of medicinal cannabis as a complementary treatment in patients with depression such as unipolar disorder. Methods: the research question was “Is it effective in using medicinal cannabis as a complementary method for treating patients with depression due to unipolar disorder?”. The databases used were PubMed and Portal Capes (published between 2018-2023), with the search strategy (Depression” OR “Psychic Symptoms”) AND (“Cannabidiol” OR “Cannabis”) AND (“Young Adult” OR “Adolescent” OR “Young”). Results: there is wo

APA, Harvard, Vancouver, ISO, and other styles

29

Pavlovsky, Federico, Rafael Groisman, Ana Karina Hurtado та Luciana García. "Cannabis de grado médico para el tratamiento de la dependencia a Δ-9-Tetrahidrocannabinol". Vertex Revista Argentina de Psiquiatría 33, № 157 (2022): 34–43. http://dx.doi.org/10.53680/vertex.v33i157.265.

Full text

Abstract:

Las adicciones son uno de los problemas de salud más importantes a nivel mundial. Dentro de estos trastornos, el cannabis es una de las sustancias psicoactivas que provoca mayor morbimortalidad a nivel mundial. La efectividad documentada de los tratamientos para los trastornos por uso de cannabis no es satisfactoria. Esta revisión tiene por objetivo explorar las evidencias sobre la implementación de tratamientos con cannabinoides para el abordaje de estos trastornos. La bibliografía actual cuenta con muchos ensayos sobre el uso de neuropsicofármacos en los trastornos por uso de cannabis con li

APA, Harvard, Vancouver, ISO, and other styles

30

Brito, Myllena Lorrainy Soares, Kathleen Moura Cajado Simões, Maria Eduarda Caetano Dias, and Matheus Santos Marques. "Impacto dos canabinóides no tratamento do Alzheimer." Brazilian Journal of Health Review 6, no. 3 (2023): 9584–97. http://dx.doi.org/10.34119/bjhrv6n3-095.

Full text

Abstract:

Introdução: A Doença de Alzheimer é uma doença neurodegenerativa progressiva e irreversível de evolução lenta que resulta na perda de memória e vários distúrbios cognitivos, apesar dos tratamentos ainda é uma doença muito difícil para o paciente e principalmente para sua família e cuidadores. O cannabidiol (CBD) é uma substância derivada da cannabis que atua no sistema nervoso central, possuindo propriedades neuroprotetoras que atuam na cognição e o comportamento dos indivíduos. Além dos efeitos neuroprotetores, o uso da cannabis medicinal pode melhorar a concentração e a memória de curto praz

APA, Harvard, Vancouver, ISO, and other styles

31

Costa, Agada Thiare, Aryane Silva, Helamã Tavares, Luan Machado, and Rychel Pereira. "Survey on the therapeutic use of Canabidiol by veterinary in the metropolitan region of Belém do Pará." Pubvet 18, no. 04 (2024): e1582. http://dx.doi.org/10.31533/pubvet.v18n04e1582.

Full text

Abstract:

The present study aimed to analyze the knowledge of veterinarians in the metropolitan region of Belém do Pará about the use of Cannabis sativa for medicinal purposes in veterinary medicine. To this end, structured questionnaires were applied through the google forms platform. The data obtained were presented in percentages, in order to collect information on this subject, which is of fundamental importance for the creation of dissemination strategies regarding the medicinal use of Cannabis, making their knowledge evident when more than 40% of respondents claim to have knowledge through scienti

APA, Harvard, Vancouver, ISO, and other styles

32

Fuentes-Pérez, Esteban Mauricio, and Liliana Patricia Acurio-Arcos. "El Cañamo (Cannabis sativa L.) para uso industrial y farmacéutico: una visión desde la industria alimentaria." CienciAmérica 9, no. 4 (2020): 99. http://dx.doi.org/10.33210/ca.v9i4.350.

Full text

Abstract:

INTRODUCCIÓN. La reciente despenalización del cáñamo (Cannabis sativa L.) para uso farmacéutico e industrial en el Ecuador, permite el desarrollo de nuevas líneas de investigación, no solamente en pro del desarrollo científico, sino también para el desarrollo de nuevos productos con características beneficiosas enfocada en la salud de quienes los consumen. OBJETIVO. El objetivo principal se centra en los posibles beneficios que la despenalización del cáñamo puede traer a la industria alimentaria. MÉTODO. Se revisaron 20 documentos científicos para realizar una lectura crítica e inferir en las

APA, Harvard, Vancouver, ISO, and other styles

33

Araujo, Joyce Isabel de, Raianne Monteiro Soares, Flávia Gymena Silva de Andrade, et al. "Uso medicinal do canabidiol no tratamento da epilepsia refratária em pacientes pediátricos: um estudo bibliográfico / The medicinal use of cannabidiol in the treatment of refrectory epilepsy in pediatric patients: a biography study." Brazilian Journal of Health Review 5, no. 3 (2022): 10281–94. http://dx.doi.org/10.34119/bjhrv5n3-193.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Kalant, Harold. "Medicinal Use of Cannabis: History and Current Status." Pain Research and Management 6, no. 2 (2001): 80–91. http://dx.doi.org/10.1155/2001/469629.

Full text

Abstract:

OBJECTIVE: To provide an overview of the history and pharmacology of cannabis in relation to current scientific knowledge concerning actual and potential therapeutic uses of cannabis preparations and pure cannabinoids.METHODS: The literature on therapeutic uses of cannabis and cannabinoids was assessed with respect to type of study design, quality and variability of data, independent replications by the same or other investigators, magnitude of effects, comparison with other available treatments and reported adverse effects. The results of this review were also compared with those of major int

APA, Harvard, Vancouver, ISO, and other styles

35

Guiliana, Gretta Del Primo De Menezes, Mombeli Karolainy, and Orientador: Prof. Gustavo José Vasco Pereira Professor. "EFICÁCIA DO CANABIDIOL NO TRATAMENTO DA ACNE." RevistaFT 28, no. 135 (2024): 53. https://doi.org/10.5281/zenodo.11649153.

Full text

Abstract:

A <em>Cannabis sativa</em> é o termo científico ou botânico, é popularmente conhecida no Brasil como maconha. A planta possui propriedades psicotrópicas e medicinais Os primeiros registros sobre o uso da<em> Cannabis</em> com fins medicinais foram atribuídos ao imperador Shen Neng, da China, em 2737 a.C Os compostos principais e mais utilizados são o tetrahidrocanabinol (THC) e o canabidiol (CBD).Objetivo: analisar e descrever  os estudos e  benefícios do uso do canabidiol no uso terapêutico no tratament

APA, Harvard, Vancouver, ISO, and other styles

36

Voigt, Luiza Regina, Isabela Angeli de Lima, and Élcio José Bunhak. "USO DE DERIVADOS DA Cannabis sativa NO TRATAMENTO DA FIBROMIALGIA: UMA REVISÃO DE LITERATURA." Acta Biologica Brasiliensia 8, no. 1 (2025): 97–110. https://doi.org/10.18554/k1b9gv41.

Full text

Abstract:

Fibromyalgia is a chronic condition that significantly compromises the quality of life of affected patients. This prevalent rheumatological disease is characterized by chronic musculoskeletal pain, fatigue, sleep disturbances, and psychological issues. The global prevalence varies from 0.2% to 6.6%, with a higher incidence in women. In addition to the physical and psychological impact, fibromyalgia generates high costs for healthcare systems due to the constant need for medical assistance. In this context, the use of derivatives from Cannabis sativa, such as tetrahydrocannabinol (THC) and cann

APA, Harvard, Vancouver, ISO, and other styles

37

Villela Gherardi, Alexandre Matheus, and Patricia Susana Salguero. "Use of Cannabis in people with autism spectrum disorder." Interdisciplinary Rehabilitation / Rehabilitacion Interdisciplinaria 5 (January 1, 2025): 34. http://dx.doi.org/10.56294/ri202534.

Full text

Abstract:

Introduction: Autism Spectrum Disorder (ASD) is a neurodevelopmental disorder characterized by impaired communication, social interaction, and repetitive or stereotyped behaviors in those affected. It presents with a wide range of symptoms, which can vary from mild to severe.Method: a search was conducted in the PubMed, SciELO databases, and the book Cannabis Medicinal. Articles were downloaded from the cited platforms to make the appropriate citations and references in Portuguese, Spanish, and English, covering the last 5 years.Results: The use of medicinal cannabis in treating Autism Spectru

APA, Harvard, Vancouver, ISO, and other styles

38

Lachenmeier, Dirk W., and Patrick Diel. "A Warning against the Negligent Use of Cannabidiol in Professional and Amateur Athletes." Sports 7, no. 12 (2019): 251. http://dx.doi.org/10.3390/sports7120251.

Full text

Abstract:

Cannabidiol (CBD) is a non-psychoactive cannabinoid, widely marketed to athletes for claimed effects such as decreased anxiety, fear memory extinction, anti-inflammatory properties, relief of pain and for post-exercise recovery. The World Anti-Doping Agency (WADA) has excluded CBD from its list of prohibited substances. Nevertheless, caution is currently advised for athletes intending to use the compound—except CBD, all other cannabinoids are still on the prohibited list. CBD products, specifically non-medicinal, so-called full-spectrum cannabis extracts, may contain significant levels of thes

APA, Harvard, Vancouver, ISO, and other styles

39

BILALIS, Dimitrios, Stella KARIDOGIANNI, Ioannis ROUSSIS, Varvara KOUNELI, Ioanna KAKABOUKI, and Antigolena FOLINA. "Cannabis sativa L.: A New Promising Crop for Medical and Industrial Use." Bulletin of University of Agricultural Sciences and Veterinary Medicine Cluj-Napoca. Horticulture 76, no. 2 (2019): 145. http://dx.doi.org/10.15835/buasvmcn-hort:2019.0020.

Full text

Abstract:

The cannabis plant was discovered 10,000 years ago without its exact use being known in China and Central Asia. Equally highly interested in this plant are the pharmaceutical and construction sectors. The cultivation of Cannabis sativa L. varieties containing more than 0.2% tetrahydrocannabinol (THC) has been legalized by the law 4523/2018 in Greece for the sole purpose of producing end-products of medicinal cannabis. The use of medicinal cannabis is important for dealing with chronic diseases. As far as cannabis cultivated for industrial use is concerned, there is a significant increase in th

APA, Harvard, Vancouver, ISO, and other styles

40

Oyuela Sierra, Evelyn Karina, Lucy Melissa Lopez, Emily Dalila Pagoaga Maldonado, et al. "Aplicaciones terapéuticas de Cannabis sativa en neuropatías: Revisión sistemática en América Latina." Portal de la Ciencia, no. 20 (June 19, 2025): 55–85. https://doi.org/10.5377/pc.v1i20.20414.

Full text

Abstract:

Este artículo presenta una revisión sistemática de la literatura sobre las aplicaciones terapéuticas de Cannabis sativa en el tratamiento del dolor neuropático en América Latina, con énfasis en neuropatías diabéticas y neuralgia postherpética. Los cannabinoides, especialmente tetrahidrocannabinol (THC) y cannabidiol (CBD), actúan en el sistema endocannabinoide, modulando procesos inflamatorios y nociceptivos, lo que les confiere propiedades analgésicas relevantes. Diversos estudios reportan que estos compuestos reducen significativamente el dolor, sobre todo en pacientes con condiciones resist

APA, Harvard, Vancouver, ISO, and other styles

41

Arellano, D., O. Díaz, H. Soto Molina, and Y. Escobar Juárez. "PAM1 SYSTEMATIC REVIEW OF THE USE OF TETRAHYDROCANNABINOL AND CANNABIDIOL AS A MEDICINAL ALTERNATIVE IN MULTIPLE SCLEROSIS." Value in Health 23 (May 2020): S10. http://dx.doi.org/10.1016/j.jval.2020.04.054.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Cruz, Felipe Tsuruta Lisboa, Rachel Vicente Silva, Aline Cristina Pereira dos Santos, Allan Rodrigues Coutinho, and Raquel Carvalho Castiglione. "The use of cannabinoids in the treatment of multiple sclerosis." Concilium 23, no. 21 (2023): 219–30. http://dx.doi.org/10.53660/clm-2449-23s43.

Full text

Abstract:

Cannabis sativa is a component of the group of psychotropic cannabinoids and its main active component is tetrahydrocannabinol (THC). Its influence on the medial prefrontal cortex is complex, and its dose-dependency is high. Cannabis sativa is the third most used substance in the world, after cigarettes and alcohol. Currently, it is being used for illegal recreational purposes and medicinal purposes in complementary therapy. Cannabidiol (CBD) can be found in 60 subtypes of Cannabis sativa and has a therapeutic effect, being used to treat various diseases. In patients with multiple sclerosis, i

APA, Harvard, Vancouver, ISO, and other styles

43

Rios, Agnes Victória Pimentel, Andreza Muritiba Gonçalves Da Silva, Ester Vieira Silva, Everton dos Santos Rocha, Gabriel Lopes Madeira Nascimento, and Keylla dos Santos Pádua. "APLICAÇÃO DA Cannabis sativa L.: MECANISMOS DE AÇÃO E POTENCIAIS TRATAMENTOS." Revista Contemporânea 3, no. 12 (2023): 27578–89. http://dx.doi.org/10.56083/rcv3n12-146.

Full text

Abstract:

O presente estudo tem como objetivo mostrar os efeitos benéficos de medicamentos à base da Cannabis sativa para determinadas doenças como Glaucoma, Epilepsia e Autismo. Esse artigo trata-se de um estudo de revisão de literatura, realizada através do levantamento de informações pertencentes a artigos científicos encontrados nas bases de dados Google Acadêmico, Scielo e Bireme, publicados entre os anos de 2013 a 2023. Estudos têm mostrado que o efeito terapêutico da C. sativa tem resultado positivo na diminuição da pressão intraocular de pacientes com glaucoma, redução de convulsões em pacientes

APA, Harvard, Vancouver, ISO, and other styles

44

Kuhathasan, Nirushi, Luciano Minuzzi, James MacKillop, and Benicio N. Frey. "The Use of Cannabinoids for Insomnia in Daily Life: Naturalistic Study." Journal of Medical Internet Research 23, no. 10 (2021): e25730. http://dx.doi.org/10.2196/25730.

Full text

Abstract:

Background Insomnia is a prevalent condition that presents itself at both the symptom and diagnostic levels. Although insomnia is one of the main reasons individuals seek medicinal cannabis, little is known about the profile of cannabinoid use or the perceived benefit of the use of cannabinoids in daily life. Objective We conducted a retrospective study of medicinal cannabis users to investigate the use profile and perceived efficacy of cannabinoids for the management of insomnia. Methods Data were collected using the Strainprint app, which allows medicinal cannabis users to log conditions and

APA, Harvard, Vancouver, ISO, and other styles

45

Patel, Rushin, Mrunal Patel, Zalak Patel, Himanshu Kavani, Darshil Patel, and Safia Shaikh. "Analyzing the medical use of cannabis for cancer patients: a critical perspective." International Journal Of Community Medicine And Public Health 11, no. 3 (2024): 1349–54. http://dx.doi.org/10.18203/2394-6040.ijcmph20240644.

Full text

Abstract:

The utilization of cannabis in oncology presents a multifaceted approach to addressing the complex challenges associated with cancer treatment. With roots tracing back to ancient medicinal practices, cannabis contains numerous compounds, including cannabinoids like tetrahydrocannabinol (THC) and cannabidiol (CBD), that interact with the body's endocannabinoid system. These interactions offer potential therapeutic benefits, ranging from antiemetic and analgesic effects to the inhibition of cancer growth processes. While clinical evidence supports the efficacy of cannabinoids in managing symptom

APA, Harvard, Vancouver, ISO, and other styles

46

Ravindra, B. Malabadi, S. Mammadova Simuzar, P. Kolkar Kiran, MR Sadiya, K. Chalannavar Raju, and Viviana Castaño Coronado Karen. "Cannabis sativa: A therapeutic medicinal plant-global marketing updates." World Journal of Biology Pharmacy and Health Sciences 17, no. 2 (2024): 170–83. https://doi.org/10.5281/zenodo.11294625.

Full text

Abstract:

Cannabis has been used for thousands of years for recreational, medicinal, or religious purposes and the therapeutic potential of medicinal Cannabis was demonstrated in various medical conditions. The legalization of Cannabis is an important source of economic growth as it contributes to the growing revenue tax, and the creation of new workplaces. The maturity of the Cannabis market varies across the globe mainly due to differing legal environments and public attitudes towards Cannabis. Some countries such as Canada and the United States have adopted fully regulated frameworks that allow the c

APA, Harvard, Vancouver, ISO, and other styles

47

Aguirre-Velázquez, Carlos G. "Report from a Survey of Parents Regarding the Use of Cannabidiol (Medicinal cannabis) in Mexican Children with Refractory Epilepsy." Neurology Research International 2017 (2017): 1–5. http://dx.doi.org/10.1155/2017/2985729.

Full text

Abstract:

Structured online surveys were used to explore the experiences of the parents of children with refractory epilepsy using medicinal cannabis in Mexico during September 2016. The surveys, which were completed in full, were reviewed, and 53 cases of children aged between 9 months and 18 years were identified. Of these, 43 cases (82%) were from Mexico and 10 (18%) were from Latin American countries. Of the 43 Mexican cases, the diagnoses were as follows: 20 cases (47%) had Lennox-Gastaut syndrome (LGS); 13 cases (30%) had unspecified refractory epilepsy (URE); 8 cases (19%) had West syndrome (WS);

APA, Harvard, Vancouver, ISO, and other styles

48

Garcia, Alícia Victória de Oliveira, Amanda Yumi Dantas Yosimoto, Gabriella Gonçalves Rosa, et al. "Efeitos adversos do uso terapêutico de Canabidiol no tratamento da epilepsia: um estudo de revisão integrativa." Brazilian Journal of Health Review 7, no. 1 (2024): 1095–105. http://dx.doi.org/10.34119/bjhrv7n1-083.

Full text

Abstract:

A epilepsia é uma condição neurológica, sendo a crise convulsiva o principal sintoma nas crises epiléticas. Pacientes em tratamento com medicamentos antiepilépticos buscam alternativas terapêuticas e a cannabis, devido aos seus compostos ativos, especialmente ao Canabidiol (CBD) e Delta-9-tetrahidrocanabinol (THC), demonstrou potencial na redução das convulsões e no alívio de sintomas associados à epilepsia, e melhora na qualidade de vida. Identificar os possíveis efeitos adversos dos medicamentos à base de Canabidiol usados como opção terapêutica no tratamento de pacientes com epilepsia. Estu

APA, Harvard, Vancouver, ISO, and other styles

49

Reis e Silva, Thainá, Anne Beatriz Rufino de Moura, Camilly Vitória Santiago Santos, et al. "Histórico, evolução e aplicações dos canabinoides na medicina veterinária: da tradição ao uso terapêutico moderno." Pubvet 19, no. 06 (2025): e1782. https://doi.org/10.31533/pubvet.v19n06e1782.

Full text

Abstract:

The use of cannabinoids in veterinary medicine has gained increasing attention due to their therapeutic potential in treating various clinical conditions, including chronic pain, epilepsy, behavioral disorders, and inflammatory diseases. This study aims to examine the evolution of cannabinoid use in veterinary medicine by exploring their mechanisms of action, therapeutic benefits, regulatory challenges, and future prospects. A narrative literature review was conducted, with a bibliographic search performed in the SciELO, Scopus, PubMed, and Web of Science databases using combinations of terms

APA, Harvard, Vancouver, ISO, and other styles

50

Simei, João Luís Q., José Diogo R. Souza, João Francisco Pedrazzi, et al. "Research and Clinical Practice Involving the Use of Cannabis Products, with Emphasis on Cannabidiol: A Narrative Review." Pharmaceuticals 17, no. 12 (2024): 1644. https://doi.org/10.3390/ph17121644.

Full text

Abstract:

Background: Emerging evidence supports cannabidiol (CBD) as a promising therapeutic compound for various health conditions, despite its approval as a medication (product for medical purposes) remaining restricted to a limited range of clinical indications. Simultaneously, the regulation of cannabis-derived products for medicinal and recreational use has expanded their global market availability to meet local community demands. This scenario presents a complex challenge for clinicians, researchers, and industry, as the global appeal of therapeutic uses of CBD is growing more rapidly than the sc

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!